Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Type I interferons play a key role in the development of various skin diseases.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Alopecia areata involves immune response and gene changes affecting hair loss.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Natural plant products like Proanthocyanidins and curcumin may help treat ischemic stroke by reducing inflammation.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.